Plain-English translation of NCT07052578 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This is an observational study — meaning researchers will follow your medical care rather than test a new drug. The study focuses on men with aggressive, advanced prostate cancer that is still sensitive to hormone therapy. Researchers will collect information about your treatment, and take blood samples to analyze your tumor's genetic profile, specifically looking for mutations in genes related to DNA repair.
Some prostate cancers have genetic changes that affect how well they respond to treatment. By studying these genetic markers in patients like you, researchers hope to better understand treatment patterns and outcomes, which could eventually help doctors choose the most effective therapy for each patient.
You likely qualify if…
You likely don't qualify if…
You will have two visits over approximately 12 months. At your first visit, researchers will review your medical records to understand your diagnosis, treatment history, and disease characteristics, and you'll provide a blood sample for genetic testing. At your second visit (around 12 months later, or sooner if your cancer progresses), researchers will collect follow-up information about how your disease has changed and any new treatments you've received. All of this happens within your routine cancer care — no extra procedures beyond what you're already doing.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
Russia